AM ResearchBioprinting

CELLINK to Collaborate with MIT on Bioprinting of Heart Valves and Pancreas

Stay up to date with everything that is happening in the wonderful world of AM via our LinkedIn community.

CELLINK entered a collaborative research agreement with Professor Robert S. Langer’s lab at the Massachusetts Institute of Technology. The lab is recognized as the largest biomedical engineering lab in the world with over 100 researchers. The collaboration is initially a one-year collaboration involving several different research projects.

The first project is aiming to create a 3D bioprinted biomimetic heart valve with correct mechanical properties achieved through elastic polymers and hydrogels and resident cell-populations. The goal is to combine CELLINK’s technology platform and the Langer lab’s researchers to produce a prototype that in the future could be tested in an in-vivo sheep-model. In the US alone, over 100,000 valve replacement surgeries are made per year. This project could provide a novel solution where CELLINK’s technology would be a critical element for the success of future heart valve replacements.

Another project is addressing the growing issue of diabetes. Solely in the US 30 million people currently have diabetes. One strategy to help this patient base is to replace their pancreas with modified autologous or allogeneic insulin-producing cells which would eliminate the need for frequent insulin injections. The difficulty has been to create implants that survive in-vivo. In this project, bioprinting will be used to try a new approach where the hope is to gain higher survival rates of cells as well as higher insulin production.

In both these projects, CELLINK will be the technology provider as well as a provider of expertise within bioprinting technology, the research collaboration will hopefully lead to verified technology and advances in the respective research fields.


CELLINK has created one of the world’s first universal Bioinks, today used by many of the world’s most well-reputed research institutions. A Bioink can be mixed with living cells to print functional human tissues and if future research is successful, eventually, complete human organs in so-called 3D-Bioprinters. CELLINK’s universal Bioink shows excellent results and can be used in both CELLINK’s proprietary 3D Bioprinters and in 3D Bioprinters developed by other operators.

Research 2021
Ceramic AM Market Opportunities and Trends

This market study from 3dpbm Research provides an in-depth analysis and forecast of the ceramic additive ma...

3D Printing Media Network

3D Printing Media Network is the online trade media portal published by 3dpbm, a leading marketing and market research firm specializing in the AM industry. 3dpbm also publishes the 3D Printing Business Directory, the AM Focus eBook series and the 3dpbm Research AM Market Reports. 3D Printing Media Network was founded with the goal to provide the latest industry news, insights and opinions to a global audience of professionals and decision makers.

Related Articles

Back to top button

We use cookies to give you the best online experience and for ads personalisation. By agreeing you accept the use of cookies in accordance with our cookie policy.

Privacy Settings saved!
Privacy Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies are necessary for the website to function and cannot be switched off in our systems.

In order to use this website we use the following technically required cookies
  • wordpress_test_cookie
  • wordpress_logged_in_
  • wordpress_sec

Decline all Services
Accept all Services



Join industry leaders and receive the latest insights on what really matters in AM!

This information will never be shared with 3rd parties

I’ve read and accept the privacy policy.*